University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 0I-05-2


 
Description: Open-Label Pharmacokinetic Trial of Aldesleukin (rh-Interleukin-2 [IL-2]) Administered Intravenously to Subjects with Metastatic Renal Cell Carcinoma or Metastatic Melanoma with Immunologic Correlative Studies.
Status: Open
Randomized? No


Researchers  
Principal InvestigatorTitle
David QuinnM.D.

Data Management
NameTitle
Charlean KetchensD.M.
Lagrimas IlaganD.M.
Roberto TejadaD.M.
Carrie KornR.N.
Marile GarciaD.M.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.